Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.

Autor: Abro B; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN., Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY., Chapman JR; Department of Pathology & Laboratory Medicine, University of Miami, Miami, FL., Cohen JB; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Friedberg JW; Department of Medical Oncology, Wilmot Cancer Center, University of Rochester, Rochester, NY., Inghirami G; Department of Pathology, Weill Cornell Medicine, New York, NY., Kahl BS; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO., Larson MC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Link BK; Division of Hematology, Oncology, and Blood & Marrow Transplantation, The University of Iowa, Iowa City, IA., Lossos IS; Department of Medicine, University of Miami, Miami, FL., Martin P; Department of Medicine, Weill Cornell Medicine, New York, NY., McDonnell TJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Nastoupil LJ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Riska SM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Syrbu S; Department of Pathology, The University of Iowa, Iowa City, IA., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Vij KR; Department of Pathology, Washington University School of Medicine, St. Louis, MO., Flowers CR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Jaye DL; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA., Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Publikováno v: Blood [Blood] 2024 Nov 07; Vol. 144 (19), pp. 2063-2066.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

Autor: Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Link BK; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Feldman AL; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota, USA., Habermann TM; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Jaye DL; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA., Burack WR; Department of Pathology, University of Rochester, Rochester, New York, USA., McDonnell TJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chapman JR; Department of Pathology, Division of Hematopathology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Syrbu S; Department of Pathology, University of Iowa, Iowa City, Iowa, USA., Vij KR; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri, USA., Inghirami G; Department of Pathology, Weill Cornell Medicine, New York, New York, USA., Leonard JP; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Bernal-Mizrachi L; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Farooq U; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Witzig TE; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Weiner GJ; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Wang Y; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Alderuccio JP; Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Slager SL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Larson MC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Riska SM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Gysbers BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Lunde JJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Reicks TW; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Ayers AA; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., O'Leary CB; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Yost KJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Liu H; Department of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, Minnesota, USA., Nowakowski GS; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ruan J; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Koff JL; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, New York, USA., Thompson CA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Cohen JB; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Kahl BS; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lossos IS; Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Friedberg JW; Department of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, Minnesota, USA., Martin P; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Flowers CR; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 408-421. Date of Electronic Publication: 2024 Jan 13.

Genes associated with bowel metastases in ovarian cancer.

Autor: Mariani A; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Wang C; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Oberg AL; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Riska SM; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Torres M; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Kumka J; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Multinu F; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Sagar G; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Roy D; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Jung DB; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Zhang Q; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Grassi T; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Visscher DW; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Patel VP; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Jin L; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Staub JK; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Cliby WA; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Weroha SJ; Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Kalli KR; Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Hartmann LC; Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Kaufmann SH; Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Goode EL; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Shridhar V; Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: shridhar.vijayalakshmi@mayo.edu.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2019 Sep; Vol. 154 (3), pp. 495-504. Date of Electronic Publication: 2019 Jun 14.

An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.

Autor: DeRycke MS; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Larson MC; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Nair AA; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., McDonnell SK; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., French AJ; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Tillmans LS; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Riska SM; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Baheti S; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Fogarty ZC; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Larson NB; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., O'Brien DR; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Cheville JC; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Wang L; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America., Schaid DJ; Department of Health Sciences Research, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America., Thibodeau SN; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, SW, Rochester, Minnesota, United States of America.

Publikováno v: PloS one [PLoS One] 2019 Apr 08; Vol. 14 (4), pp. e0214588. Date of Electronic Publication: 2019 Apr 08 (Print Publication: 2019).

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

Autor: Kommoss S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany., Winterhoff B; Division of Gynecologic Surgery, Mayo Clinic, Minnesota.; Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minnesota., Oberg AL; Department of Health Sciences Research, Mayo Clinic, Minnesota., Konecny GE; Division of Medical Oncology, UCLA, California., Wang C; Department of Health Sciences Research, Mayo Clinic, Minnesota., Riska SM; Department of Health Sciences Research, Mayo Clinic, Minnesota., Fan JB; AnchorDx Corporation, Guangzhou, China.; Illumina Inc., San Diego, California., Maurer MJ; Department of Health Sciences Research, Mayo Clinic, Minnesota., April C; Illumina Inc., San Diego, California., Shridhar V; Department of Laboratory Medicine, Mayo Clinic, Minnesota., Kommoss F; Institute of Pathology, Mannheim, Germany., du Bois A; Kliniken Essen Mitte (KEM), Deptartment of Gynecology and GynecologicOncology, Essen, Germany., Hilpert F; Department of Gynecology and Obstetrics, Schleswig-Holstein University, Kiel, Germany., Mahner S; Department of Obstetrics and Gynecology, Ludwig Maximillian University Munich, Germany., Baumann K; Department of Gynecology and Gynecologic Oncology, Philipps University Marburg, Germany., Schroeder W; Gynaecologicum Bremen, Bremen, Germany., Burges A; Klinikum der Universitaet Muenchen, Campus Grosshadern, Klinik und Poliklinik fuer Frauenheilkunde und Geburtshilfe, Munich, Germany., Canzler U; Department of Gynecology and Obstetrics, Technical University Dresden, Dresden, Germany., Chien J; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, Kansas., Embleton AC; Medical Research Council Clinical Trials Unit at University College London, UK., Parmar M; Medical Research Council Clinical Trials Unit at University College London, UK., Kaplan R; Medical Research Council Clinical Trials Unit at University College London, UK., Perren T; Leeds Institute of Cancer Medicine and Pathology, University of Leeds, UK., Hartmann LC; Division of Medical Oncology, Mayo Clinic, Minnesota., Goode EL; Department of Health Sciences Research, Mayo Clinic, Minnesota., Dowdy SC; Division of Gynecologic Surgery, Mayo Clinic, Minnesota. dowdy.sean@mayo.edu., Pfisterer J; Gynecologic Oncology Center, Kiel, Germany.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Jul 15; Vol. 23 (14), pp. 3794-3801. Date of Electronic Publication: 2017 Feb 03.